Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?

European Journal of Pediatrics

Volumn 166, Issue 1, 2007, Pages 23-28

  De Boeck, Kris ^a   De Baets, Frans ^b   Malfroot, Anne ^d   Desager, Kristine ^c   Mouchet, Françoise ^d   Proesmans, Marijke ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Cystic fibrosis; Growth; Inhaled corticosteroids; Lung function; Prepubertal

Indexed keywords

FLUTICASONE PROPIONATE; LACTULOSE; PLACEBO;

ANALYSIS OF VARIANCE; ARTICLE; BODY HEIGHT; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; GROWTH DISORDER; HUMAN; LUNG FUNCTION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM;

ADMINISTRATION, INHALATION; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; CHILD; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; TIME FACTORS;

EID: 33845388432     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0198-9     Document Type: Article

References (27)

1. American Thoracic Society (1987) Standardisation of spirometry-1987 update. Am Rev Respir Dis 136:1285-1298
2. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF, Phelan PD (1997) Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 156:1197-1204
3. Avital A, Sanchez I, Chernick V (1992) Efficacy of salbutamol and ipratropium bromide in decreasing bronchial hyperreactivity in children with cystic fibrosis. Pediatr Pulmonol 13:34-37
4. Balfour-Lynn IM, Klein NJ, Dinwiddie R (1997) Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis. Arch Dis Child 77:124-130
5. Bisgaard H, Pedersen SS, Nielsen KG, Skov M, Laursen EM, Kronborg G, Reimert CM, Hoiby N, Koch C (1997) Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 156:1190-1196
6. Brasfield D, Hicks G, Soong S, Tiller R (1979) The chest radiograph in cystic fibrosis: a new scoring system. Pediatrics 63:24-29
7. Dezateux C, Walters S, Balfour-Lynn I (2000) Inhaled corticosteroids for cystic fibrosis. Cochrane Database Syst Rev 2:CD001915
8. Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV (1995) A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 126:515-523
9. Koch C, McKenzie SG, Kaplowitz H, Hodson ME, Harms HK, Navarro J, Mastella G (1997) International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF). Pediatr Pulmonol 24:147-154
10. Kolls JK, Beckerman RC (1991) Will ABPA occur in your patient with cystic fibrosis? J Respir Dis 12:137-146
11. Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA (1999) Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol 28:248-254
12. Konstan MW, Byard PJ, Hoppel CL, Davis PB (1995) Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 332:848-854
13. Konstan MW, Walenga RW, Hilliard KA, Hilliard JB (1993) Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis 48:896-901
14. Nikolaizik WH, Schoni MH (1996) Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis. J Pediatr 128:271-274
15. Parmar JS, Howell T, Kelly J, Bilton D (2002) Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 57:749-750
16. Pedersen S, Hansen OR (1995) Budseonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 95:29-33
17. Puchelle E, De Bentzmann S, Hubeau C, Jacquot J, Gaillard D (2001) Mechanisms involved in cystic fibrosis airway inflammation. Pediatr Pulmonol 23(Suppl):143-145
18. Quanjer PH, Stocks J, Polgar G, Wise M, Karlberg J, Borsboom G (1989) Compilation of reference values for lung function measurements in children. Eur Respir J 2:184s-261s
19. Rosenstein BJ, Cutting GR (1998) The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132:563-565
20. Schiotz PO, Jorgensen M, Flensborg EW, Faero O, Husby S, Hoiby N, Jacobsen SV, Nielsen H, Svehag SE (1983) Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment. Acta Paediatr Scand 72:283-287
21. Schmidt J, Davidson AGF, Seear M, Wong LTK, Peacock D, Gravel A, Menon K, Cimolai N, Speert DP (1997) Is the acquisition of pseudomonas in cystic fibrosis patients increased by use of inhaled corticosteroids? Unexpected results from a double blind placebo controlled study. In: Proceedings of the 11th Annual North American Cystic Fibrosis Conference
22. Simons FE (1997) A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 337:1659-1665
23. The Childhood Asthma Management Program Research Group (2000) Long-term effects of budesonide or nedrocromil in children with asthma. N Engl J Med 343:1054-1063
24. Todd GRG, Acerini CL, Ross-Russel R, Zahra S, Warner JT, McCance D (2002) Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 87:457-461
25. Van Haren EHJ, Lammers JWJ, Festen J, Heijerman HG, Groot CA, van Herwaarden CL (1995) The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. Respir Med 89:209-214
26. Verberne AA, Frost C, Roorda RJ, van der Laag H, Kerrebijn KF (1997) One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med 156:688-695
27. Wojtczak HA, Kerby GS, Wagener JS, Copenhaver SC, Gotlin RW, Riches DW, Accurso FJ (2001) Beclomethasone dipropionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: a pilot study. Pediatr Pulmonol 32:293-302